DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression

Näytä kaikki kuvailutiedot

Permalink

http://hdl.handle.net/10138/298910

Lähdeviite

Mäki-Nevala , S , Valo , S , Ristimaki , A , Sarhadi , V , Knuutila , S , Nyström , M , Renkonen-Sinisalo , L , Lepistö , A , Mecklin , J-P & Peltomäki , P 2019 , ' DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression ' , EBioMedicine , vol. 39 , pp. 280-291 . https://doi.org/10.1016/j.ebiom.2018.12.018

Julkaisun nimi: DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression
Tekijä: Mäki-Nevala, Satu; Valo, Satu; Ristimaki, Ari; Sarhadi, Virinder; Knuutila, Sakari; Nyström, Minna; Renkonen-Sinisalo, Laura; Lepistö, Anna; Mecklin, Jukka-Pekka; Peltomäki, Päivi
Muu tekijä: University of Helsinki, Department of Medical and Clinical Genetics
University of Helsinki, Department of Medical and Clinical Genetics
University of Helsinki, Department of Pathology
University of Helsinki, Department of Pathology
University of Helsinki, Department of Pathology
University of Helsinki, Genetics
University of Helsinki, Department of Surgery
University of Helsinki, Department of Surgery
University of Helsinki, Department of Medical and Clinical Genetics
Kuuluu julkaisusarjaan: EBioMedicine
ISSN: 2352-3964
Tiivistelmä: Background: DNA mismatch repair (MMR) defects are a major factor in colorectal tumorigenesis in Lynch syndrome (LS) and 15% of sporadic cases. Some adenomas from carriers of inherited MMR gene mutations have intact MMR protein expression implying other mechanisms accelerating tumorigenesis. We determined roles of DNA methylation changes and somatic mutations in cancer-associated genes as tumorigenic events in LS-associated colorectal adenomas with intact MMR. Methods: We investigated 122 archival colorectal specimens of normal mucosae, adenomas and carcinomas from 57 LS patients. MMR-deficient (MMR-D, n 49) and MMR-proficient (MMR-P, n 18) adenomas were of particular interest and were interrogated by methylation-specific multiplex ligation-dependent probe amplification and Ion Torrent sequencing. Findings: Promoter methylation of CpG island methylator phenotype (CIMP)-associated marker genes and selected colorectal cancer (CRC)-associated tumor suppressor genes (TSGs) increased and LINE-1 methylation decreased from normal mucosa to MMR-P adenomas to MMR-D adenomas. Methylation differences were statistically significant when either adenoma group was compared with normal mucosa, but not between MMR-P and MMR-D adenomas. Significantly increased methylation was found in multiple CIMP marker genes (1612, NEUROGI,CRABP1, and CDKN2A) and TSGs (SERPI and SFRP2) in MMR-P adenomas already. Furthermore, certain CRC-associated somatic mutations, such as KRAS, were prevalent in MMR-P adenomas. Interpretation: We conclude that DNA methylation changes and somatic mutations of cancer-associated genes might serve as an alternative pathway accelerating LS-associated tumorigenesis in the presence of proficient MMR. Fund: Jane and Aatos Erkko Foundation, Academy of Finland, Cancer Foundation Finland, Sigrid juselius Foundation, and HiL1FE. (C) 2019 Published by Elsevier B.V.
URI: http://hdl.handle.net/10138/298910
Päiväys: 2019-01
Avainsanat: Lynch syndrome
Colorectal adenoma
DNA methylation
DNA mismatch repair
UNE-1 methylation
Mutation
Tumotigenesis
Tumor suppressor
MICROSATELLITE INSTABILITY
COLORECTAL ADENOMAS
BRAF MUTATION
COPY NUMBER
CANCER
GENE
DEFICIENCY
PHENOTYPE
TUMORS
HYPOMETHYLATION
3111 Biomedicine
3121 Internal medicine
Tekijänoikeustiedot:


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
1_s2.0_S2352396418305954_main.pdf 545.6KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot